WSAAI 2024 61st Annual Scientific Session
The Western Society of Allergy Asthma & Immunology (WSAAI) consistently delivers high-quality, scientific lectures in the field of Allergy & Clinical Immunology in a unique format promoting attendee interaction with some of the foremost researchers and clinicians in our specialty. Such conferences have been our notable achievement for over five decades. Among the subjects covered in the upcoming program address various topics around asthma such as Asthma Phenotyping, management of childhood asthma, biologic therapy for asthma; Food Allergen Immunotherapy and new and emerging therapies for food allergy; Chronic cough and cough hypersensitivity and trials and tribulations in chronic cough.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the Western Society of Allergy Asthma & Immunology (WSAAI). The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 20 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 20 contact hours.
Target Audience
Practicing allergists
Primary care physicians
Allied healthcare professionals
Learning Objectives
At the conclusion of this activity, learners should be able to…
1. Summarize the relative efficacy of biologic therapies for the treatment of asthma and describe immune pathways that may indicate responsiveness to several of these therapies.
2. Demonstrate a broad knowledge of food allergen therapies in the development or approval pipeline, including potential application into clinical practice in the future.
3. Describe the mechanisms underlying chronic cough.
4. Identify patients with suspected mast cell disorders who should have additional workup for potential targeted treatment.
All relevant financial relationships with ineligible companies have been mitigated.
Kimberly G. Blumenthal, MD, MSc, Speaker
Independent contractor – Thermofisher Scientific
Mark Boguniewicz, MD, Speaker
Advisor – AbbVie, Amgen, Dermavant, Eli Lilly, Janssen, Incyte, Leo Pharma, Pfizer, Regeneron, Sanofi Genzyme
Independent contractor – Incyte, Regeneron, Sanofi Genzyme
Noam A. Cohen, MD, PhD, Speaker
Advisor – GSK, Sanofi/Regeneron
Independent contractor – GeneOne Life Sciences
Royalties/patent beneficiary – GeneOne Life Sciences
David Elkayam, MD, Planner, Moderator
Consultant – Siva
Researcher – Allergy Therapeutics, AstraZeneca, Bellus Health, Genentech, Novartis, Siva, Suzhou
Stacie M. Jones, MD, Speaker
Advisor – Aimmune
Researcher – Aimmune, ALK-Abello, Aravax PTY, DBV Technologies, Genentech, Regeneron
Research advisory board – Regeneron
Lorcan McGarvey, MD, FRCP
Advisor – AstraZeneca, Chiesi, GSK, Merck
Speaker – AstraZeneca, Chiesi, GSK, Merck
Consultant – Genentech, Nocion Therapeutics
Joshua Milner, MD, Speaker
Advisor – Blueprint Medicines
Marc Riedl, MD, MS, Planner
Consultant – Astria, BioCryst, Biomarin, Celldex, CSL Behring, Cycle Pharma, Grifols, Intellia, KalVista, Pfizer, Pharming, Pharvaris, Sanofi/Regeneron, Takeda
Researcher – BioCryst, Biomarin, CSL Behring, Ionis, KalVista, Pharvaris, Takeda
Speaker – CSL Behring, Grifols, Pharming, Takeda
Stanley Szefler, MD, Speaker
Advisor – Moderna
Consultant – AstraZeneca, GSK, OM Pharma, Regeneron, Sanofi
Researcher – Eli Lilly, Propeller Health
Amy Wagelie-Steffen, MD, Planner
Advisor – BioCryst, Pharming
Consultant – BioCryst, Pharming
Speaker – Amgen, AstraZeneca, Genentech, Sanofi/Regeneron
Sally E. Wenzel, MD, Speaker
Advisor – Aer Therapeutics
Researcher – Pieris, Regeneron
Stocks – Aer Therapeutics
Andrew White, MD, Planner, Moderator
Advisor – Amgen, AstraZeneca, Blueprint, Cogent, GSK, Optinose, Sanofi/Regeneron
Researcher – AstraZeneca, Sanofi/Regeneron
Speaker – AstraZeneca, Blueprint, GSK, Optinose, Sanofi/Regeneron
The following have no relevant financial relationships with ineligible companies to disclose:
Matthew C. Altman, MD, Speaker
Amy Klion, MD, Speaker
René Anderson-Cowell, MD, Planner, Moderator
Steven Machtinger, MD, Planner, Moderator
Jinny Chang, MD, Planner
Karol Anderson, Planner
Available Credit
- 20.00 AMA PRA Category 1 Credit™
- 20.00 Attendance
- 20.00 CBRN